Lumenis Ltd. Announces First Quarter 2014 Earnings Conference Call

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

YOKNEAM, ISRAEL--(Marketwired - April 29, 2014) - Lumenis Ltd. (NASDAQ: LMNS), the world’s largest medical laser company for surgical, ophthalmology and aesthetic applications, today announced plans to release its first quarter fiscal 2014 financial results on Monday, May 12, 2014, after market close.

In conjunction with the release, management will host a conference call on Monday, May 12, 2014, at 5:00 p.m. (Eastern). To listen to the conference call on your telephone, please dial the following numbers approximately ten minutes prior to the start of the call: 888-389-5988 for callers based in the United States, 1-80-924-5906 for callers based in Israel and 719-325-2432 for callers based in all other countries. The reservation code for the call is 9972028. A live webcast of the conference call will also be available on the investor relations page of the company’s website at http://investor.lumenis.com.

A telephone replay of the call will be available for 14 days following the call. To listen to the replay, please dial 888-203-1112 for United States-based callers and 719-457-0820 for international callers. The reservation code is 9972028. A replay of the webcast will be available on the investor relations page of the company’s website.

About Lumenis
Lumenis (NASDAQ: LMNS) is a global leader in the field of minimally-invasive clinical solutions for the Surgical, Ophthalmology and Aesthetic markets, and is a world-renowned expert in developing and commercializing innovative energy-based technologies, including Laser, Intense Pulsed Light (IPL) and Radio-Frequency (RF). For nearly 50 years, Lumenis’ ground-breaking products have redefined medical treatments and have set numerous technological and clinical gold-standards. Lumenis has successfully created solutions for previously untreatable conditions, as well as designed advanced technologies that have revolutionized existing treatment methods in each and every one of the verticals we operate in. Our drive for innovation stems from an uncompromising commitment to improving the health and well-being of our patients; addressing new and growing needs of aging populations; and in offering medical professionals cutting-edge solutions that fit seamlessly into the health-economics environment of the 21st century. The world over, we bring Energy to Healthcare.

For more information visit: www.lumenis.com


For Investor Inquiries:
Mark Klausner or Michael Piccinino, CFA
Westwicke Partners, LLC.
443.213.0500
Email Contact

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC